"They haven't added a simpler, likely cheaper therapy for RA to the drug formularies yet."
You want to know why? It's because they aren't entirely certain if injecting this type of therapy—say, into a knee—might trigger the growth of unintended tissues, like tumors. At least, that’s what I gathered from reading the FDA website. But let's be real: their goal isn't necessarily to rush a cheap therapy into hospitals, though they'll eventually have to. The future belongs to stem cells—they're going to regenerate joints, fix organs, and tackle all sorts of other diseases.
To be honest, I haven't seen anything suggesting that Lipogems provides long-term relief specifically for those dealing with RA. With Lipogems, how long does it actually last for people? Maybe 2-3 years, maybe 3-5? And it's incredibly expensive because they have to harvest fat from each individual patient to create a custom batch of tissue-regenerating cells just for them.
Cynata Therapeutics, a firm out of Australia, is kicking off Phase 2 clinical trials this year for their "allogeneic" stem cell approach—using one donor to supply everyone. Once these stem cells become commercialized, they’ll become very affordable. Their first phase was a success, so I don't doubt the second will be too. This is shaping up to be the largest stem cell trial ever conducted globally regarding osteoarthritis.
Then there's Paradigm Biopharma. That company has a product that could hit the market in just a few years; they've already cleared Phase 2 successfully. The protocol involves injections twice a week for six weeks (into the gluteus), and then you're looking at being pain-free for 6, 12, or even 24 months. You won't wear down your cartilage (or at least, very little), the joint inflammation disappears, and the knee pain stops. The clinical trials were focused on knees. It’s not a steroid, it’s not an NSAID, it isn't addictive, and it doesn't have any harmful effects on the body.🙂
There was this 31-year-old guy who was actually a candidate for a partial knee replacement. He had already signed up for the surgery, but instead, he joined this trial. His pain level was a 10/10—he literally couldn't walk. He received the treatment, and today? He's running every single day 12 miles and only feels a little pain once in a while, maybe a 1 or 2.
In case anyone is interested: